Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs. (Q48216057)

9 February 2018

title

Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs. (English)

1 reference

9 February 2018

0 references

1 reference

Kuenstler U

1

1 reference

9 February 2018

Juhnhold U

series ordinal

2

1 reference

9 February 2018

Knapp WH

series ordinal

3

1 reference

9 February 2018

Gertz HJ

series ordinal

4

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 February 1999

1 reference

9 February 2018

published in

Psychiatry Research

1 reference

9 February 2018

volume

90

1 reference

9 February 2018

page(s)

31-39

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

A rating scale for drug-induced akathisia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Clozapine: neuroleptic-induced EPS and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Neuroleptic withdrawal in schizophrenic patients. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Reevaluation of the mesolimbic hypothesis of antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

D2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2898%2900054-7

7 January 2021

10.1016/S0925-4927(98)00054-7

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

10320209

1 reference

9 February 2018